Encision revenue grows 7%
BOULDER — Medical device manufacturer Encision Inc. (PK: ECIA) experienced 7% revenue growth in the first quarter of its 2023 fiscal year, the company reported Tuesday.
Encision increased its revenue year-over-year to $2.15 million from $2.01 million in the first quarter of its 2022 fiscal year.
The company also brought in net earnings of $265,000, or 2 cents per share, compared with a loss of $7,000 a year ago.
“The first quarter presented significant challenges for Encision,” Encision chief executive Gregory Trudel said in a prepared statement. “During the first quarter of fiscal year 2023 and fiscal year 2022, COVID resurgences continued to…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!